Nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
activates	O
proenkephalin	O
transcription	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Upon	O
activation	O
,	O
T	B-cell_type
lymphocytes	I-cell_type
accumulate	O
high	O
levels	O
of	O
the	O
neuropeptide	O
enkephalin	O
which	O
correlate	O
with	O
high	O
levels	O
of	O
proenkephalin	B-RNA
mRNA	I-RNA
in	O
the	O
cells	O
.	O

Here	O
we	O
investigated	O
the	O
transcriptional	O
basis	O
for	O
these	O
changes	O
.	O

The	O
proenkephalin	O
promoter	O
contains	O
a	O
sequence	O
GGGGACGTCCCC	O
,	O
named	O
B2	B-DNA
,	O
which	O
is	O
similar	O
to	O
the	O
kappa	B-DNA
B	I-DNA
sequence	I-DNA
GGGGACTTTCC	O
,	O
the	O
binding	O
site	O
of	O
the	O
transcription	B-protein
factor	I-protein
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappa	I-protein
B	I-protein
.	O

Activation	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
induces	O
an	O
NF-kappa	B-protein
B	I-protein
-like	O
binding	O
activity	O
to	O
the	O
B2	B-DNA
site	O
,	O
concomitant	O
with	O
activation	O
of	O
the	O
proenkephalin	B-DNA
promoter	I-DNA
.	O

Mutations	O
at	O
the	O
B2	B-DNA
site	O
abolish	O
this	O
transcriptional	O
activation	O
.	O

The	O
purified	O
homodimer	B-protein
(	O
two	O
p50s	B-protein
)	O
of	O
the	O
DNA-binding	B-protein
subunit	I-protein
of	O
NF-kappa	B-protein
B	I-protein
binds	O
the	O
B2	B-DNA
site	O
of	O
proenkephalin	O
relatively	O
better	O
than	O
does	O
the	O
heterotetramer	B-protein
(	O
two	O
p65s	B-protein
plus	O
two	O
p50s	B-protein
)	O
form	O
of	O
the	O
factor	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
the	O
T-cell-specific	O
activation	O
of	O
the	O
proenkephalin	B-DNA
promoter	I-DNA
is	O
mediated	O
by	O
NF-kappa	B-protein
B	I-protein
.	O

However	O
,	O
as	O
NF-kappa	B-protein
B	I-protein
is	O
ubiquitous	O
and	O
the	O
transcriptional	O
activation	O
through	O
the	O
B2	B-DNA
site	O
is	O
T	O
cell	O
specific	O
,	O
yet	O
another	O
T-cell-specific	B-protein
factor	I-protein
which	O
synergizes	O
with	O
NF-kappa	B-protein
B	I-protein
should	O
be	O
considered	O
.	O

